{"Title": "Small and large intestinal involvement and nutritional issues", "Year": 2016, "Source": "Scleroderma: From Pathogenesis to Compr. Management", "Volume": null, "Issue": null, "Art.No": null, "PageStart": 443, "PageEnd": 458, "CitedBy": 0, "DOI": "10.1007/978-3-319-31407-5_31", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85018882208&origin=inward", "Abstract": "\u00a9 Springer Science+Business Media New York 2017.Most patients with systemic sclerosis develop gastrointestinal manifestations. The small intestine, large intestine, and anorectal regions are affected in 40-80 %, 20-50 %, and 50-70 % of patients, respectively. Gastrointestinal manifestations may increase morbidity and mortality, reduce quality of life, and result in malnutrition.", "AuthorKeywords": ["Anatomic aspects of intestinal involvement", "Intestinal failure", "Motility aspects of intestinal involvement", "Nutrition", "Small and large intestinal involvement and management"], "IndexKeywords": null, "DocumentType": "Book", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85018882208", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"35973677200": {"Name": "Harrison E.", "AuthorID": "35973677200", "AffiliationID": "60003771", "AffiliationName": "Institute of Inflammation and Repair, University of Manchester"}, "57202223898": {"Name": "Murray C.", "AuthorID": "57202223898", "AffiliationID": "60170516", "AffiliationName": "Department of Gastroenterology, Royal Free London NHS Trust"}, "7203075074": {"Name": "Lal S.", "AuthorID": "7203075074", "AffiliationID": "60008873", "AffiliationName": "Intestinal Failure Unit, Salford Royal NHS Foundation Trust"}}}